Nanomaterials for Immunomodulation and Immunotherapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 30 January 2025 | Viewed by 60
Special Issue Editors
Interests: mRNA vaccines; nanomedicine; nanotherapeutics; nanotoxicology; nano-bio interface; nanoEHS; nanomaterial library and high throughput screening; occupational and environmental toxicology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, titled "Nanomaterials for Immunomodulation and Immunotherapy", is focused on advancing our understanding of the nanomaterials used in the field of immunology. This issue aims to provide a comprehensive overview of the current understanding of and state-of-the-art research on the activation/tolerance mechanisms of nanomaterials, involving immune cells and the subsequent effect responses.
This Special Issue’s aim is to bring together researchers and experts in the field to discuss the latest advancements, trends, and challenges in research, including, but not limited to, the following: physical/chemical parameters modulating immune signaling pathways and effector functions in distinct immune cell subtypes, such as dendritic cells, macrophages, T cells, natural killer cells, and B cells; the modulation of physical characteristics in nanomaterials at the nano–bio interface, impacting and determining the biological features of nano-based immunotherapy, nanoparticle structure–activity relationships, emerging strategies/new methodologies, and technologies for safe nano-immunotherapy design by manipulating nano–bio interactions. This collection will build on and extend current knowledge of nano–bio interactions by incorporating new perspectives and insights from recent research. The purpose of this Special Issue is to provide an up-to-date and comprehensive resource for researchers, practitioners, policymakers, and the general public, and to help further our understanding of the mechanisms behind nanomaterial and nanomedicine design in the field of immunology.
Dr. Xiang Wang
Dr. Qi Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- immunotherapy
- immunomodulation
- vaccines
- biomaterials
- physicochemical properties
- nanomedicine
- nano–bio interactions
